Skip to main content
Clinical Trials/NL-OMON51253
NL-OMON51253
Withdrawn
Not Applicable

Functional gait training as complementary treatment to botulinum toxin type A in patients with disabling dystonia due to Parkinson*s disease: a double-blind randomized controlled clinical trial. - Gait training as complementary treatment in patients with dystonia.

Radboud Universitair Medisch Centrum0 sites30 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dystonia
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
30
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • The main inclusion criterium consists of idiopathic Parkinson\*s disease and the
  • presence of dystonia resulting in varus tilt of the hindfoot when walking. In
  • addition, participants should be able to walk 100 meters and be able to follow
  • instructions.

Exclusion Criteria

  • Participants will be excluded if they:
  • Have severe cognitive impairments
  • Have other neurologic or orthopedic impairments that cause problems when
  • Are not able to walk 100 meters independently

Outcomes

Primary Outcomes

Not specified

Similar Trials